Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug Response Differences to Pegylated Recombinant Human Growth Hormone in Children with Growth Hormone Deficiency
ChiCTR2200055588Phase 4Completed
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Jan 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of peg-somatropin in growth hormone deficiency (GHD), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoint: Metabolomic profile by GC-TOFMS. Started Jan 2018; status: completed.
02
Drugs
peg-somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on ChiCTR2200055588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055588.